Home / Methylphenidate / Canada
CA ATC N06BA04 · updated 2 Nov 2026
Methylphenidate shortage in Canada
Is there a Methylphenidate shortage in Canada?
Yes. As of 2 Nov 2026, 6 Methylphenidate products are reported short in Canada, the first since 30 Jan 2018. The company estimate for the return is 13 Nov 2026 (latest 15 Nov 2026). Main reason: manufacturing problem.
Also short in United States, France, Belgium, Norway, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-METHYLPHENIDATE ER-C (100) | TEVA CANADA LIMITED | 30 Jan 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-METHYLPHENIDATE ER-C (100) | TEVA CANADA LIMITED | 30 Jan 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-METHYLPHENIDATE ER-C (100) | TEVA CANADA LIMITED | 30 Jan 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-METHYLPHENIDATE ER-C (100) | TEVA CANADA LIMITED | 30 Jan 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-METHYLPHENIDATE CR (100) | PHARMASCIENCE INC | 22 May 2026 | 15 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-METHYLPHENIDATE (100 BTL) | APOTEX INC | 29 Sep 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.